Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Iezzi

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|September 14, 2018
Immunomodulation Mediated by Anti-angiogenic Therapy Improves CD8 T Cell Immunity Against Experimental GliomaCourtney S Malo, Roman H Khadka, Katayoun Ayasoufi, et al.
Acta Biomaterialia|December 14, 2017
Fibrin hydrogels as a xenofree and rapidly degradable support for transplantation of retinal pigment epithelium monolayersJarel K Gandhi, Zahid Manzar, Lori A Bachman, et al.
Eye (London, England)|September 23, 2022
Incidence of metformin use in patients with age-related macular degeneration versus normal controls: A population-based study in Olmsted County, MinnesotaMatthew R Starr, Lauren A Dalvin, Jackson E AbouChehade, et al.
Plos One|January 14, 2020
Fibrin hydrogels are safe, degradable scaffolds for sub-retinal implantationJarel K Gandhi, Fukutaro Mano, Raymond Iezzi, et al.
American Journal of Ophthalmology|January 27, 2019
The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery-A Population-based StudySasha A Mansukhani, Andrew J Barkmeier, Sophie J Bakri, et al.
American Journal of Ophthalmology|June 26, 2018
The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery-A Population-based StudySasha A Mansukhani, Andrew J Barkmeier, Sophie J Bakri, et al.
JAMA Ophthalmology|February 1, 2019
Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular DegenerationLauren A Dalvin, Matthew R Starr, Jackson E AbouChehade, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 18, 2019
Classification of Strokes in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth FactorMatthew R Starr, Lauren A Dalvin, Jackson E AbouChehade, et al.
Frontiers in Cell and Developmental Biology|January 30, 2026
Degradable fibrin hydrogels for transplantation of iPSC-derived retinal pigment epithelial cell monolayersAlan D Marmorstein, Brittni A Scruggs, Travis Knudsen, et al.
American Journal of Ophthalmology|August 6, 2022
Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor InjectionsSaumya M Shah, Nithya Boopathiraj, Matthew R Starr, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|September 14, 2018
Immunomodulation Mediated by Anti-angiogenic Therapy Improves CD8 T Cell Immunity Against Experimental GliomaCourtney S Malo, Roman H Khadka, Katayoun Ayasoufi, et al.
Acta Biomaterialia|December 14, 2017
Fibrin hydrogels as a xenofree and rapidly degradable support for transplantation of retinal pigment epithelium monolayersJarel K Gandhi, Zahid Manzar, Lori A Bachman, et al.
Eye (London, England)|September 23, 2022
Incidence of metformin use in patients with age-related macular degeneration versus normal controls: A population-based study in Olmsted County, MinnesotaMatthew R Starr, Lauren A Dalvin, Jackson E AbouChehade, et al.
Plos One|January 14, 2020
Fibrin hydrogels are safe, degradable scaffolds for sub-retinal implantationJarel K Gandhi, Fukutaro Mano, Raymond Iezzi, et al.
American Journal of Ophthalmology|January 27, 2019
The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery-A Population-based StudySasha A Mansukhani, Andrew J Barkmeier, Sophie J Bakri, et al.
American Journal of Ophthalmology|June 26, 2018
The Risk of Primary Open-Angle Glaucoma Following Vitreoretinal Surgery-A Population-based StudySasha A Mansukhani, Andrew J Barkmeier, Sophie J Bakri, et al.
JAMA Ophthalmology|February 1, 2019
Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular DegenerationLauren A Dalvin, Matthew R Starr, Jackson E AbouChehade, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 18, 2019
Classification of Strokes in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth FactorMatthew R Starr, Lauren A Dalvin, Jackson E AbouChehade, et al.
Frontiers in Cell and Developmental Biology|January 30, 2026
Degradable fibrin hydrogels for transplantation of iPSC-derived retinal pigment epithelial cell monolayersAlan D Marmorstein, Brittni A Scruggs, Travis Knudsen, et al.
American Journal of Ophthalmology|August 6, 2022
Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor InjectionsSaumya M Shah, Nithya Boopathiraj, Matthew R Starr, et al.
Pageof 9